Skip to content

BASYL

Active
Private limited companyfounded 1997active for 28 yearsChemin Fourneau 4, 1400 Nivelles, BelgiumKBO/BCE: BE 0462.036.734
Summary

BASYL has been active since 1997 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €202,994 and a net result of €33,857. Equity remains stable across the filed financial years (±1% per year). Its solvency ranks better than 40% of 2,944 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€426,042total assets 2025
Equity
€202,994
Profit
€33,857
Turnover not published (abbreviated or micro format)
Financial health
94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts filed 44 days late0 of 4 deeds read
Why 94raises riskLatest accounts 44 days late; 3 of the last 3 latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.30, cash €258,088Equity €202,994 (47.6% of total assets)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 50% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 73+6
equity 47.6% of total assets
Liquidity 100=
short-term debt 10.0% · cash 60.6%
Profitability 42-9
return on assets 7.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,042 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: 0.1%▲ +0.1 percentage points vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: < 0.1%▼ -0.1 percentage points vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025highest value 10-2025: < 0.1%▼ -0.1 percentage points vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €19,000 on 30-day terms is acceptable
Liquidity ample (current ratio 6.3, compared with 5.34 in 2024, above the usual 1.5; short-term debt: 10% and cash: 60.6% of total assets), but 52.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 38% on solvency, 90% on liquidity, 7% on profitability and 64% on growth.

The bankruptcy probability was computed on 12-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Latest accounts 44 days late; 3 of the last 3 late
NBB · filings
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 6.30, cash €258,088
NBB · annual accounts
lowers risk · Equity €202,994 (47.6% of total assets)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €202,994
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-09-2026, 44 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
44 days late
2024
55 days late
2023
51 days late
2022
7 days late
2021
72 days late
2020
124 days late
2019
90 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 63 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 21 September (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
13-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Equity above €200,000equity €202,994 ▲20%
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, abbreviated format

Equity
€202,994▲ 20.0%
2024 · €169,137
Total assets
€426,042▲ 5.8%
2024 · €402,824
Net result
€33,857▼ 20.2%
2024 · €42,429
Working capital
€226,382▲ 23.0%
2024 · €184,111
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result recovers in 2025; 2025 is 28% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€218,924 2025 Net result€33,857 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€14,154-€5,946▼ 58.0%€99,355▲ 1,571%€116,548▲ 17.3%-€13,205€203,014€171,702▼ 15.4%€218,924▲ 27.5%
Net result€5,696--€1,032€42,625within the sector's middle half€30,206within the sector's middle half▼ 29.1%-€81,834below the sector's middle half€57,672within the sector's middle half€42,429within the sector's middle half▼ 26.4%€33,857within the sector's middle half▼ 20.2%
Equity€182,391-€181,359▼ 0.6%€223,984within the sector's middle half▲ 23.5%€209,083within the sector's middle half▼ 6.7%€69,037within the sector's middle half▼ 67.0%€126,709within the sector's middle half▲ 83.5%€169,137within the sector's middle half▲ 33.5%€202,994within the sector's middle half▲ 20.0%
Total assets€329,261-€317,493▼ 3.6%€383,905within the sector's middle half▲ 20.9%€347,235within the sector's middle half▼ 9.6%€294,518within the sector's middle half▼ 15.2%€325,013within the sector's middle half▲ 10.4%€402,824within the sector's middle half▲ 23.9%€426,042within the sector's middle half▲ 5.8%
Debt€146,870-€136,134▼ 7.3%€159,921▲ 17.5%€138,152▼ 13.6%€115,156▼ 16.6%€92,221▼ 19.9%€88,112▼ 4.5%€65,867▼ 25.2%
Working capital€54,986-€56,611▲ 3.0%€87,517within the sector's middle half▲ 54.6%€72,789within the sector's middle half▼ 16.8%€33,896within the sector's middle half▼ 53.4%€95,447within the sector's middle half▲ 182%€184,111within the sector's middle half▲ 92.9%€226,382within the sector's middle half▲ 23.0%
Solvency55.4%-57.1%▲ 1.7pp58.3%within the sector's middle half▲ 1.2pp60.2%within the sector's middle half▲ 1.9pp23.4%below the sector's middle half▼ 36.8pp39.0%within the sector's middle half▲ 15.5pp42.0%within the sector's middle half▲ 3.0pp47.6%within the sector's middle half▲ 5.7pp
Current ratio2.57-2.39▼ 0.183.23within the sector's middle half▲ 0.832.41within the sector's middle half▼ 0.821.59within the sector's middle half▼ 0.812.56within the sector's middle half▲ 0.975.34within the sector's middle half▲ 2.786.30within the sector's middle half▲ 0.96
Return on assets (ROA)1.7%--0.3%▼ 2.1pp11.1%within the sector's middle half▲ 11.4pp8.7%within the sector's middle half▼ 2.4pp-27.8%below the sector's middle half▼ 36.5pp17.7%within the sector's middle half▲ 45.5pp10.5%within the sector's middle half▼ 7.2pp7.9%within the sector's middle half▼ 2.6pp
Staff (FTE)0.1-0.1=
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated or micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €426,042
Fixed assets €156,926 ▼ 11.0%
Current assets €269,116 ▲ 18.8%
Equity and liabilities €426,042
Equity €202,994 ▲ 20.0%
Provisions €157,181 ▲ 8.0%
Debt €65,867 ▼ 25.2%
Debt's share of the balance-sheet total falls from 21.9% to 15.5%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€260,304▲
2024 · €226,119
Cash flow
€75,237▼
2024 · €96,846
Quick ratio
6.26▲
2024 · 5.29
Debt to equity
0.32▼
2024 · 0.52
ROE
16.7%▼
2024 · 25.1%
Interest coverage
1.60▼
2024 · 2.31
Debt ≤ 1 year
€42,734▲
2024 · €42,414
Debt > 1 year
€22,733▼
2024 · €45,698
Income taxes
€23,546▼
2024 · €33,330
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 31,372 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 93.5% are still going.

  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.5% went bankrupt
5.9% stopped otherwise
93.5% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,468 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 31,372 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 57 lines
Balance sheet Code20242025
Assets
Total assets20/58€402,824€426,042▲
Fixed assets21/28€176,299€156,926▼
Tangible fixed assets22/27€176,299€156,926▼
Land and buildings22€94,332€74,900▼
Plant, machinery and equipment23€635€476▼
Furniture and vehicles24€55,622€38,915▼
Other tangible fixed assets26€25,710€42,635▲
Current assets29/58€226,525€269,116▲
Stocks and contracts in progress3€2,130€1,624▼
Stocks30/36€2,130€1,624▼
Amounts receivable within one year40/41€51,404€4,269▼
Trade receivables40€484€4,269▲
Other amounts receivable41€50,920-
Cash at bank and in hand54/58€167,129€258,088▲
Deferred charges and accrued income490/1€5,862€5,134▼
Equity and liabilities
Total equity and liabilities10/49€402,824€426,042▲
Equity10/15€169,137€202,994▲
Contributions10/11€6,197€6,197=
Contributions outside capital11€6,197€6,197=
Other1109/19€6,197€6,197=
Reserves13€81,895€111,895▲
Non-distributable reserves130/1€1,895€1,895=
Legal reserve130€1,895€1,895=
Distributable reserves133€80,000€110,000▲
Profit (loss) carried forward14€81,045€84,902▲
Provisions and deferred taxes16€145,575€157,181▲
Provisions for liabilities and charges160/5€145,575€157,181▲
Other liabilities and charges164/5€145,575€157,181▲
Amounts payable17/49€88,112€65,867▼
Amounts payable after more than one year17€45,698€22,733▼
Financial debts170/4€45,698€22,733▼
Amounts payable within one year42/48€42,414€42,734▲
Current portion of amounts payable after more than one year42€27,549€22,965▼
Trade debts44€3,717€3,240▼
Suppliers440/4€3,717€3,240▼
Taxes, remuneration and social security45€11,147€14,400▲
Taxes450/3€11,147€14,400▲
Other amounts payable47/48-€2,129
Accrued charges and deferred income492/3-€400
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€54,418€41,380▼
Provisions for liabilities and charges: additions (uses and reversals)635/8€39,492€11,606▼
Other operating charges640/8€13,127€7,704▼
Non-recurring operating charges66A€93€71▼
Gross operating margin9900€278,831€279,685▲
Operating profit (loss)9901€171,702€218,924▲
Financial income75/76B€1,995€1,062▼
Recurring financial income75€1,995€1,062▼
Financial charges65/66B€97,938€162,583▲
Recurring financial charges65€97,938€162,583▲
Profit (loss) for the period before taxes9903€75,759€57,403▼
Income taxes67/77€33,330€23,546▼
Profit (loss) for the period9904€42,429€33,857▼
Profit (loss) for the period to be appropriated9905€42,429€33,857▼
Appropriation of the result
Profit (loss) to be appropriated9906€111,045€114,902▲
Profit (loss) brought forward from the previous period14P€68,616€81,045▲
Transfer to equity691/2€30,000€30,000=
To other reserves6921€30,000€30,000=

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Non-recurring operating income76A----€360----
Remuneration, social security and pensions62---€1,425-----
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€36,788€27,351€39,582€42,903€41,197€43,272€54,418€41,380▼ 24.0%
Provisions for liabilities and charges: additions (uses and reversals)635/8----€110,325-€4,242€39,492€11,606▼ 70.6%
Other operating charges640/8---€5,633€4,126€7,657€13,127€7,704▼ 41.3%
Non-recurring operating charges66A---€411€199-€93€71▼ 23.7%
Gross operating margin9900€56,589€39,316€154,933€166,920€142,642€249,701€278,831€279,685▲ 0.3%
Operating profit (loss)9901€14,154€5,946€99,355€116,548-€13,205€203,014€171,702€218,924▲ 27.5%
Financial income75/76B---€739€1,509€1,928€1,995€1,062▼ 46.8%
Recurring financial income75€889€1,250€1,294€739€1,509€1,928€1,995€1,062▼ 46.8%
Financial charges65/66B---€71,442€57,479€123,237€97,938€162,583▲ 66.0%
Recurring financial charges65€3,250€2,718€45,004€71,442€57,473€123,237€97,938€162,583▲ 66.0%
Non-recurring financial charges66B----€5----
Profit (loss) for the period before taxes9903€11,793€4,478€55,645€45,845-€69,175€81,705€75,759€57,403▼ 24.2%
Income taxes67/77€6,097€5,510€13,019€15,640€12,659€24,033€33,330€23,546▼ 29.4%
Profit (loss) for the period9904€5,696-€1,032€42,625€30,206-€81,834€57,672€42,429€33,857▼ 20.2%
Profit (loss) for the period to be appropriated9905€5,696€8,468€42,625€30,206-€81,834€57,672€42,429€33,857▼ 20.2%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€329,261€317,493€383,905€347,235€294,518€325,013€402,824€426,042▲ 5.8%
Fixed assets21/28€239,356€220,282€257,092€222,683€203,423€168,337€176,299€156,926▼ 11.0%
Tangible fixed assets22/27€239,356€220,282€257,092€222,683€203,423€168,337€176,299€156,926▼ 11.0%
Land and buildings22---€158,645€137,207€115,769€94,332€74,900▼ 20.6%
Plant, machinery and equipment23---€5,127€3,366€1,605€635€476▼ 25.0%
Furniture and vehicles24---€43,188€30,985€23,368€55,622€38,915▼ 30.0%
Other tangible fixed assets26---€15,722€31,864€27,594€25,710€42,635▲ 65.8%
Current assets29/58€89,905€97,211€126,813€124,552€91,095€156,677€226,525€269,116▲ 18.8%
Stocks and contracts in progress3€6,410€11,215€1,308€1,693€1,069€2,112€2,130€1,624▼ 23.8%
Stocks30/36---€1,693€1,069€2,112€2,130€1,624▼ 23.8%
Amounts receivable within one year40/41€45,085€53,182€29,779€25,184€37,327€36,579€51,404€4,269▼ 91.7%
Trade receivables40---€923-€4,421€484€4,269▲ 782%
Other amounts receivable41---€24,260€37,327€32,158€50,920--
Cash at bank and in hand54/58€33,605€28,662€89,701€92,098€46,808€114,039€167,129€258,088▲ 54.4%
Deferred charges and accrued income490/1---€5,577€5,892€3,946€5,862€5,134▼ 12.4%
Equity and liabilities
Total equity and liabilities10/49€329,261€317,493€383,905€347,235€294,518€325,013€402,824€426,042▲ 5.8%
Equity10/15€182,391€181,359€223,984€209,083€69,037€126,709€169,137€202,994▲ 20.0%
Contributions10/11€6,552€6,552-€6,552€6,197€6,197€6,197€6,197=
Contributions outside capital11---€6,552€6,197€6,197€6,197€6,197=
Other1109/19---€6,552€6,197€6,197€6,197€6,197=
Reserves13€56,502€47,002€47,002€21,895€21,895€51,895€81,895€111,895▲ 36.6%
Non-distributable reserves130/1---€1,895€1,895€1,895€1,895€1,895=
Legal reserve130------€1,895€1,895=
Reserves not available under the articles1311---€1,895€1,895€1,895---
Distributable reserves133---€20,000€20,000€50,000€80,000€110,000▲ 37.5%
Profit (loss) carried forward14€119,337€127,805€170,430€180,636€40,944€68,616€81,045€84,902▲ 4.8%
Provisions and deferred taxes16----€110,325€106,083€145,575€157,181▲ 8.0%
Provisions for liabilities and charges160/5----€110,325€106,083€145,575€157,181▲ 8.0%
Other liabilities and charges164/5----€110,325€106,083€145,575€157,181▲ 8.0%
Amounts payable17/49€146,870€136,134€159,921€138,152€115,156€92,221€88,112€65,867▼ 25.2%
Amounts payable after more than one year17€111,154€95,535€120,625€84,531€57,957€30,991€45,698€22,733▼ 50.3%
Financial debts170/4---€84,531€57,957€30,991€45,698€22,733▼ 50.3%
Amounts payable within one year42/48€34,919€40,599€39,296€51,763€57,200€61,230€42,414€42,734▲ 0.8%
Current portion of amounts payable after more than one year42---€26,189€26,574€26,966€27,549€22,965▼ 16.6%
Trade debts44€2,527€15,767€10,694€2,486€3,979€4,304€3,717€3,240▼ 12.8%
Suppliers440/4---€2,486€3,979€4,304€3,717€3,240▼ 12.8%
Taxes, remuneration and social security45---€23,087€26,646€29,961€11,147€14,400▲ 29.2%
Taxes450/3---€18,013€20,646€27,361€11,147€14,400▲ 29.2%
Remuneration and social security454/9---€5,074€6,001€2,600---
Other amounts payable47/48-------€2,129-
Accrued charges and deferred income492/3---€1,858---€400-
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€5,696-€1,032€42,625€30,206-€81,834€57,672€42,429€33,857▼ 20.2%
+ Depreciation and write-downs630€36,788€27,351€39,582€42,903€41,197€43,272€54,418€41,380▼ 24.0%
Operating cash flow (approximation)€42,484€26,319€82,207€73,108-€40,638€100,945€96,846€75,237▼ 22.3%
Investment in fixed assets (approximation)--€8,277-€76,392-€8,494-€21,936-€8,186-€62,380-€22,008▲ 64.7%
Change in cash--€4,943€61,040€2,397-€45,290€67,232€53,089€90,959▲ 71.3%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 25 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 abbreviated format 13-09-2026 2026-00512214
31-12-2024 micro format 24-09-2025 2025-00503337
31-12-2023 micro format 20-09-2024 2024-00466536
31-12-2022 micro format 07-08-2023 2023-00326149
31-12-2021 micro format 11-10-2022 2022-20456882
31-12-2020 micro format 02-12-2021 2021-79000351
31-12-2019 micro format 29-10-2020 2020-64200405
31-12-2018 micro format 23-09-2019 2019-64900201
31-12-2017 micro format 09-11-2018 2018-72000370
31-12-2016 micro format 14-10-2017 2017-67300211

Show all 25 filings

Similar companies · same sector, comparable size

Of the 16,561 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,104. 6,793 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 4 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

BASYL was incorporated on 4 December 1997.1 Total assets rose from €329,261 in 2018 to €426,042 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
13-09
NBB filing Annual accounts filed
financial year 2025 · abbreviated format · 44 days late
2025
31-12
Financial Equity above €200,000equity €202,994 ▲20%
3 profitable years in a row build equity to €202,994.
24-09
NBB filing Annual accounts filed
financial year 2024 · micro format · 55 days late
2024
31-12
Financial Liquidity more than doubledcurrent ratio 5.34
Current ratio from 2.56 to 5.34; short-term debt falls from €61,230 to €42,414.
31-12
Financial Equity above €150,000equity €169,137 ▲33.5%
2 profitable years in a row build equity to €169,137.
20-09
NBB filing Annual accounts filed
financial year 2023 · micro format · 51 days late
2023
31-12
Financial Back to profitnet €57,672
Net result €57,672 after one loss-making year.
31-12
Financial Equity above €100,000equity €126,709 ▲83.5%
Equity rises from €69,037 to €126,709.
07-08
NBB filing Annual accounts filed
financial year 2022 · micro format · 7 days late
2022
31-12
Financial Weakest financial yearnet -€81,834
Net result drops to -€81,834, the lowest in the series; recovery starts the following year.
11-10
NBB filing Annual accounts filed
financial year 2021 · micro format · 72 days late
2021
02-12
NBB filing Annual accounts filed
financial year 2020 · micro format · 124 days late
Show earlier events
2020
31-12
Financial Back to profitnet €42,625
Net result €42,625 after one loss-making year.
31-12
Financial Equity above €200,000equity €223,984 ▲23.5%
Equity rises from €181,359 to €223,984.
29-10
NBB filing Annual accounts filed
financial year 2019 · micro format · 90 days late
2019
23-09
NBB filing Annual accounts filed
financial year 2018 · micro format · 54 days late
2018
09-11
NBB filing Annual accounts filed
financial year 2017 · micro format · 101 days late
2017
14-10
NBB filing Annual accounts filed
financial year 2016 · micro format · 75 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 25 annual accounts filed, the latest 10 are here; all 25 are under Financials.
0 of 4 deeds read
About the unread acts

We know of 4 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded04-12-1997
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0462036734
Also 9925:BE0462036734
Registered 22-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 13 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Legal Entity Identifier

254900YKKG7DY5WF5I14
live in the LEI register

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Nivelles · 1 establishment unit since 2016
registered office establishment The establishment unit on the map
Ground area
1,338 m²
Building footprint
202 m²
Building volume
1,051 m³
Parcel 25066A0143/00N000, Wallonia · tallest building 7.7 m. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
Chemin Fourneau 4, 1400 Nivelles
Specialist medical practice
since 2016unit no. 2.269.210.674
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
25066A0143/00N000 Wallonia 1,338 m² 1 · 202 m² 7.7 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.